Experience of using Rituximab in neurological practice (literature review and own observation)
Currently, due to the lack of specific etiotropic therapy, rituximab is widely used for the treatment of most autoimmune diseases of the central and peripheral nervous system. Rituximab is a chimeric monoclonal antibody with specificity for CD20, the antigen found on the surface of normal and malign...
Saved in:
Main Authors: | Ya. B. Kushnir, N. M. Tereshchenko, M. P. Abramova, A. A. Gotovchikov, A. Yu. Polushin, V. S. Krasnov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Academician I.P. Pavlov First St. Petersburg State Medical University
2021-11-01
|
Series: | Учёные записки Санкт-Петербургского государственного медицинского университета им. Акад. И.П. Павлова |
Subjects: | |
Online Access: | https://www.sci-notes.ru/jour/article/view/807 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Best practices in the use of human immunoglobulin preparations for intravenous administration in the treatment of rare neurological diseases
by: N. M. Tereshchenko, et al.
Published: (2023-04-01) -
Clinical polymorphism of myelitis in neurologic practice. Lecture with description of clinical cases
by: A. A. Kondratov, et al.
Published: (2024-07-01) -
IMMUNOPATHOGENESIS OF MYASTHENIA GRAVIS (REVIEW)
by: E. D. Gasymly
Published: (2018-06-01) -
Postinfectious Aquaporin-4-positive Neuromyelitis Optica Syndrome Disorder and Nephrotic Syndrome
by: Darshankumar Manubhai Raval, et al.
Published: (2025-07-01) -
The neuromyelitis optica spectrum disorders: approaches for problem resolution in medical rehabilitation
by: V. S. Krasnov, et al.
Published: (2016-09-01)